Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Emma J. Shelton is active.

Publication


Featured researches published by Emma J. Shelton.


Tetrahedron Letters | 2001

Synthesis of 3,5-disubstituted-1,2,4-oxadiazoles using tetrabutylammonium fluoride as a mild and efficient catalyst

Anthony R. Gangloff; Joane Litvak; Emma J. Shelton; David Sperandio; Vivian R. Wang; Kenneth D. Rice

Tetrabutylammonium fluoride (TBAF) was found to be a mild and efficient catalyst for the synthesis of 3,5-disubstituted-1,2,4-oxadiazoles. Using 0.1–1.0 equivalents of TBAF in THF for 1–24 h at room temperature, alkanoyl- and aroyloxyamidines were converted in high yield to the corresponding 3,5-disubstituted-1,2,4-oxadiazoles. A variety of R and R′ substituents were investigated.


Bioorganic & Medicinal Chemistry Letters | 2002

Highly potent non-peptidic inhibitors of the HCV NS3/NS4A serine protease

David Sperandio; Anthony R. Gangloff; Joane Litvak; Richard Goldsmith; Jason M. Hataye; Vivian R. Wang; Emma J. Shelton; Kyle Elrod; James W. Janc; James M. Clark; Ken Rice; Steve Weinheimer; Kap-Sun Yeung; Nicholas A. Meanwell; Dennis Hernandez; Andrew J. Staab; Brian Lee Venables; Jeffrey R. Spencer

Screening of a diverse set of bisbenzimidazoles for inhibition of the hepatitis C virus (HCV) serine protease NS3/NS4A led to the identification of a potent Zn(2+)-dependent inhibitor (1). Optimization of this screening hit afforded a 10-fold more potent inhibitor (46) under Zn(2+) conditions (K(i)=27nM). This compound (46) binds also to NS3/NS4A in a Zn(2+) independent fashion (K(i)=1microM). The SAR of this class of compounds under Zn(2+) conditions is highly divergent compared to the SAR in the absence of Zn(2+), suggesting two distinct binding modes.


Archive | 1999

Novel compounds and compositions for treating hepatitis c infections

Jason M. Hataye; Kenneth D. Rice; Emma J. Shelton; Jeffrey R. Spencer; Vivian R. Wang


Bioorganic & Medicinal Chemistry Letters | 2007

Discovery of 5-(4-hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)-7-phenyl-(E)-2,3,6,7-tetrahydro-1,4-thiazepines as a new series of apoptosis inducers using a cell- and caspase-based HTS assay.

John Drewe; Shailaja Kasibhatla; Ben Tseng; Emma J. Shelton; David Sperandio; Robert Yee; Joane Litvak; Martin Sendzik; Jeffrey R. Spencer; Sui Xiong Cai


Archive | 2001

Substituted 1,4-thiazepine and analogs and their use as activators of caspases

Sui Xiong Cai; John Drewe; Emma J. Shelton; Joane Litvak; David Sperandio; Jeffrey R. Spencer


Archive | 2003

Novel phenyl derivatives as inducers of apoptosis

Sui Xiong Cai; Ben Cebon; Joane Litvak; Keith Pararajasingham; Emma J. Shelton; Jeffrey R. Spencer; David Sperandio; Paul A. Sprengeler; Vincent W.-F. Tai; Robert Yee


Bioorganic & Medicinal Chemistry Letters | 2006

Discovery and structure-activity relationship of 2-phenyl-oxazole-4-carboxamide derivatives as potent apoptosis inducers.

Vincent W.-F. Tai; David Sperandio; Emma J. Shelton; Joane Litvak; Keith Pararajasingham; Ben Cebon; Julia Lohman; John Eksterowicz; Seema Kantak; Peter Sabbatini; Cindy Brown; Jennifer Zeitz; Chris Reed; Bill Maske; Doris Graupe; Alberto Estevez; Jason Oeh; Darren Wong; Yong Ni; Paul A. Sprengeler; Robert Yee; Catherine Magill; Anthony Neri; Sui Xiong Cai; John Drewe; Ling Qiu; John Herich; Ben Tseng; Shailaja Kasibhatla; Jeffrey R. Spencer


Tetrahedron Letters | 2006

Development of a scalable synthesis of a nonbasic inhibitor of the serine protease tryptase

Jeffrey M. Dener; Colin O’Bryan; Robert Yee; Emma J. Shelton; David Sperandio; Tania Mahajan; James T. Palmer; Jeffrey R. Spencer; Zhiwei Tong


Archive | 2001

Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof

John Drewe; Sui Xiong Cai; Emma J. Shelton; Joane Litvak; David Sperandio; Jeffrey R. Spencer; Martin Sendzik


Bioorganic & Medicinal Chemistry Letters | 2006

Identification of metabolites of the tryptase inhibitor CRA-9249: observation of a metabolite derived from an unexpected hydroxylation pathway.

Walter Yu; Jeffrey M. Dener; Daniel A. Dickman; Paul Grothaus; Yun Ling; Liang Liu; Chris Havel; Kimberly Malesky; Tania Mahajan; Colin O’Brian; Emma J. Shelton; David Sperandio; Zhiwei Tong; Robert Yee; Joyce Mordenti

Collaboration


Dive into the Emma J. Shelton's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jeffrey R. Spencer

California Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Vivian R. Wang

California State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge